HBM Buys Back HK$10 Million Shares In One Day; Looks to Form Strategic Partnerships; Shares Rise 15%

MT Newswires Live

2025/02/10

HBM Holdings (HKG:2142) repurchased HK$10 million worth of shares on Feb. 7, the most for biotech firms on the Hong Kong Stock Exchange, according to a Monday filing with the bourse.

The buyback is a part of a HK$40 million buyback plan to enhance shareholder value.

CEO and chairman of the board Jingsong Wang increased his stake in the company and did not rule out further stake increase.

With cash reserves of HK$1.43 billion, the company is strengthening its business by partnering with companies like Windward Bio and Kodiak Sciences. These collaborations aim to advance research and develop innovative treatments in key areas such as immunology and ophthalmology.

The company's shares were up by 15% in recent trading.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2510366004"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2510366004\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2510366004?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-02-10 12:26","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2510366004","market":"sh","top_or_hot":-1,"title":"HBM Buys Back HK$10 Million Shares In One Day; Looks to Form Strategic Partnerships; Shares Rise 15%","media":"MT Newswires Live","content":"<html><body><p> HBM Holdings (HKG:2142) repurchased HK$10 million worth of shares on Feb. 7, the most for biotech firms on the Hong Kong Stock Exchange, according to a Monday filing with the bourse.</p><p>The buyback is a part of a HK$40 million buyback plan to enhance shareholder value.</p><p>CEO and chairman of the board Jingsong Wang increased his stake in the company and did not rule out further stake increase.</p><p>With cash reserves of HK$1.43 billion, the company is strengthening its business by partnering with companies like Windward Bio and Kodiak Sciences. These collaborations aim to advance research and develop innovative treatments in key areas such as immunology and ophthalmology.</p><p>The company's shares were up by 15% in recent trading.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>HBM Buys Back HK$10 Million Shares In One Day; Looks to Form Strategic Partnerships; Shares Rise 15%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHBM Buys Back HK$10 Million Shares In One Day; Looks to Form Strategic Partnerships; Shares Rise 15%\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2025-02-10 12:26</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> HBM Holdings (HKG:2142) repurchased HK$10 million worth of shares on Feb. 7, the most for biotech firms on the Hong Kong Stock Exchange, according to a Monday filing with the bourse.</p><p>The buyback is a part of a HK$40 million buyback plan to enhance shareholder value.</p><p>CEO and chairman of the board Jingsong Wang increased his stake in the company and did not rule out further stake increase.</p><p>With cash reserves of HK$1.43 billion, the company is strengthening its business by partnering with companies like Windward Bio and Kodiak Sciences. These collaborations aim to advance research and develop innovative treatments in key areas such as immunology and ophthalmology.</p><p>The company's shares were up by 15% in recent trading.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02142","symbol_name":"和铂医药-B","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2510366004","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2510366004","pubTimestamp":1739161590,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"HBM Holdings  repurchased HK$10 million worth of shares on Feb. 7, the most for biotech firms on the Hong Kong Stock Exchange, according to a Monday filing with the bourse.The buyback is a part of a HK$40 million buyback plan to enhance shareholder value.CEO and chairman of the board Jingsong Wang increased his stake in the company and did not rule out further stake increase.With cash reserves of HK$1.43 billion, the company is strengthening its business by partnering with companies like Windward Bio and Kodiak Sciences. These collaborations aim to advance research and develop innovative treatments in key areas such as immunology and ophthalmology.The company's shares were up by 15% in recent trading.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02142":"和铂医药-B","BK1574":"生物医药B类股","BK1161":"生物科技","BK1583":"高瓴概念"},"translate_title":"HBM一日回购1000万港元股票；寻求建立战略合作伙伴关系；股价上涨15%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02142":0.9},"content_text":"HBM Holdings (HKG:2142) repurchased HK$10 million worth of shares on Feb. 7, the most for biotech firms on the Hong Kong Stock Exchange, according to a Monday filing with the bourse.The buyback is a part of a HK$40 million buyback plan to enhance shareholder value.CEO and chairman of the board Jingsong Wang increased his stake in the company and did not rule out further stake increase.With cash reserves of HK$1.43 billion, the company is strengthening its business by partnering with companies like Windward Bio and Kodiak Sciences. These collaborations aim to advance research and develop innovative treatments in key areas such as immunology and ophthalmology.The company's shares were up by 15% in recent trading.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}